HIMS Institutional Ownership

Hims & Hers Health, Inc.

Latest close $31.99 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 31, 2026
Public consensus preview Broad reduction 13/100 institutional research score
4 tracked institutions Latest filing Jul 31, 2026

2 reducing across 2 comparable institutions.

Accumulating0
Unchanged0
Reducing2
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$13.74 52-week high$70.43
Latest close $31.99 32.2% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026
Vanguard Capital Management Jul 31, 2026 filed
BlackRock Legacy Jan 31, 2024 filed
BlackRock Jul 28, 2026 filed
JPMorgan Chase / Asset Management Mar 5, 2026 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 8 parsed filing(s) · 5 older require more history access
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
Vanguard Capital Management CIK0002100119 Jun 30, 2026 observed Jul 31, 2026 filed · 31d Initial Schedule 13G Initial Schedule 13G 11.2M 12.00% $34.67 $27.77 $31.99
BlackRock CIK0002012383 Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment Reported reduction 26.5M -3.1M 12.00% -2.20 pts $34.67 $29.32 $31.99
JPMorgan Chase / Asset Management CIK0000019617 Feb 27, 2026 observed Mar 5, 2026 filed · 6d Schedule 13G amendment Reported reduction 3.9M -13.9M 12.00% 0.00 pts $14.52 $15.88 $31.99
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

INSM INSMED INC 13/100 Broad reduction LITE Lumentum Holdings Inc. 13/100 Broad reduction 8TG THERMON GROUP HOLDINGS INC 12/100 Broad reduction HELE HELEN OF TROY LTD 12/100 Broad reduction

Recent multi-institution accumulation

TVTX TRAVERE THERAPEUTICS INC 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026